Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Investigation

• Publication date

  2007-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI32405PMID 18060033PMCID PMC2096456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis1

  2007cited by this paper
• Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.

  2007cited by this paper
• Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.

  2007cited by this paper
• B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis1

  2007cited by this paper
• Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction.

  2007cited by this paper
• Depletion of B Cells in Murine Lupus: Efficacy and Resistance1

  2007cited by this paper
• Role of autoantibodies in type 1 diabetes.

  2007cited by this paper
• Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes.

  2006cited by this paper
• Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy

  2006cited by this paper
• Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.

  2006cited by this paper
• B Cells Are Crucial for Determinant Spreading of T Cell Autoimmunity among β Cell Antigens in Diabetes-Prone Nonobese Diabetic Mice1

  2006cited by this paper
• TGF-beta signaling is required for the function of insulin-reactive T regulatory cells.

  2006cited by this paper
• Progression of Autoimmune Diabetes

  2006cited by this paper
• TGF-β signaling is required for the function of insulin-reactive T regulatory cells

  2006cited by this paper
• Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes

  2006cited by this paper
• B cell immunobiology in disease: evolving concepts from the clinic.

  2006cited by this paper
• A Case for Regulatory B Cells1

  2006cited by this paper
• Autoantibody markers for the diagnosis and prediction of type 1 diabetes.

  2006cited by this paper
• B cells in autoimmune diabetes.

  2005cited by this paper
• B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.

  2005cited by this paper
• The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice1

  2005cited by this paper
• A Case for Regulatory B Cells

  2005cited by this paper
• Investigation of the role of B-cells in type 1 diabetes in the NOD mouse.

  2004cited by this paper
• The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy

  2004cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• Rituximab: expanding role in therapy for lymphomas and autoimmune diseases.

  2004cited by this paper
• Pathogenic roles of B cells in human autoimmunity; insights from the clinic.

  2004cited by this paper
• An essential role for Scurfin in CD4+CD25+ T regulatory cells

  2003cited by this paper
• The mechanisms of action of rituximab in the elimination of tumor cells.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Prevention of Arthritis by Interleukin 10–producing B Cells

  2003cited by this paper
• Supporting Online Material

  2003cited by this paper
• The mechanisms of action of rituximab in the elimination of tumor cells.

  2003cited by this paper
• The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

  2003cited by this paper
• B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications.

  2003cited by this paper
• Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells

  2003cited by this paper
• B cells regulate autoimmunity by provision of IL-10

  2002cited by this paper
• The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes.

  2002cited by this paper
• Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice

  2002cited by this paper
• Effective B cell depletion with rituximab in the treatment of autoimmune diseases.

  2002cited by this paper
• β-Cell death during progression to diabetes

  2001cited by this paper
• beta-Cell death during progression to diabetes.

  2001cited by this paper
• From T to B and back again: positive feedback in systemic autoimmune disease

  2001cited by this paper
• B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice.

  2001cited by this paper
• Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice1

  2001cited by this paper
• Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.

  2000cited by this paper
• Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

  1999cited by this paper
• B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.

  1998cited by this paper
• The Role of Lymphocyte Subsets in Accelerated Diabetes in Nonobese Diabetic–Rat Insulin Promoter–B7-1 (NOD-RIP-B7-1) Mice

  1998cited by this paper
• B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.

  1998cited by this paper
• Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice.

  1997cited by this paper
• B-Cells Are Required for the Initiation of Insulitis and Sialitis in Nonobese Diabetic Mice

  1997cited by this paper
• B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice

  1996cited by this paper
• Identification of the 37-kDa Antigen in IDDM as a Tyrosine Phosphatase-Like Protein (Phogrin) Related to IA-2

  1996cited by this paper
• ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules.

  1996cited by this paper
• Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

  1990cited by this paper

• Dia-B-Ties: B Cells in the Islet–Immune-Cell Interface in T1D

  2025influential citation
• Hyaluronan Accumulates in Inflamed Lymph Nodes and Promotes B‐Cell Activation

  2025cites this paper
• TCL1A in naïve B cells as a therapeutic target for type 1 diabetes

  2025cites this paper
• Autoimmune diabetes and targets for immunomodulation.

  2025cites this paper
• Monocyte/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226+ B cells in type 1 diabetes

  2025cites this paper
• Altered B cell metabolic pathways characterize type 1 diabetes progression.

  2025cites this paper
• Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease

  2025cites this paper
• Is the NOD mouse a good model for type 1 diabetes?

  2025cites this paper
• B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.

  2025cites this paper
• Can autoimmune disease be cured by deep CD19+ cell depletion?

  2025cites this paper
• Role of animal models in understanding the mechanisms of autoimmune diseases

  2025cites this paper
• Unraveling Type 1 Diabetes: Integrating Microbiome, Metabolomics, and Immunomodulation for Next-Generation Therapies

  2025cites this paper
• Blood immune cell profiling in adults with longstanding type 1 diabetes is associated with macrovascular complications

  2024cites this paper
• Cluster of differentiation molecules in the metabolic syndrome.

  2024cites this paper
• Advancing Animal Models of Human Type 1 Diabetes.

  2024cites this paper
• Single-cell analysis reveals islet autoantigen’s immune activation in type 1 diabetes patients

  2024cites this paper
• Complement Cascade Proteins Correlate with Fibrosis and Inflammation in Early-Stage Type 1 Diabetic Kidney Disease in the Ins2Akita Mouse Model

  2024cites this paper
• Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SCs) through the Galectin-9-Dependent Mechanism

  2024cites this paper
• Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases

  2024cites this paper
• The Immunology of type 1 diabetes

  2024cites this paper
• The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner

  2024cites this paper
• Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren’s disease

  2024cites this paper
• Mechanisms underlying the development of type 1 diabetes in ART-treated people living with HIV: an enigmatic puzzle

  2024cites this paper
• Altered B Cell Metabolic Pathways Characterize Type 1 Diabetes Progression

  2024cites this paper
• The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner

  2024cites this paper
• Immunosuppression Withdrawal in Living-donor Renal Transplant Recipients Following Induction with Anti-thymocyte Globulin and Rituximab: Results of a Prospective Clinical Trial.

  2024cites this paper
• The role of B cells in the pathogenesis of type 1 diabetes

  2024cites this paper
• The Role of B Lymphocytes in Type 1 Diabetes.

  2024cites this paper
• NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice

  2023cites this paper
• 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes

  2023cites this paper
• Review on Monoclonal Antibodies (mAbs) as a Therapeutic Approach for Type 1 Diabetes.

  2023cites this paper
• Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study

  2023cites this paper
• Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice

  2023cites this paper
• A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases

  2023cites this paper
• Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes.

  2023cites this paper
• Vitamin D in Diabetes: Uncovering the Sunshine Hormone’s Role in Glucose Metabolism and Beyond

  2023cites this paper
• B Cell-Directed Therapy in Autoimmunity.

  2023cites this paper
• Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes.

  2022cites this paper
• Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice

  2022cites this paper
• Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes

  2022cites this paper
• Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans

  2022cites this paper
• Modulatory role of prolactin in type 1 diabetes

  2022cites this paper
• Transient B-cell depletion and regulatory T-cells mediation in combination with adenovirus mediated IGF-1 prevents and reverses autoimmune diabetes in NOD mice

  2022influential citation
• Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes

  2022cites this paper
• Anti-CD20 therapy ameliorates β cell function and rebalances Th17/Treg cells in NOD mice

  2022influential citation
• Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome

  2022cites this paper
• Stem Cell Educator therapy in type 1 diabetes: From the bench to clinical trials.

  2022cites this paper
• Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other

  2022cites this paper
• Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes

  2022cites this paper
• Regulatory B Cells in Autoimmune Diabetes

  2021cites this paper
• Current and future therapies for type 1 diabetes

  2021cites this paper
• Influence of PTPN22 Allotypes on Innate and Adaptive Immune Function in Health and Disease

  2021cites this paper
• Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology

  2021cites this paper
• B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes

  2021cites this paper
• Blood leukocytes recapitulate diabetogenic peptide–MHC-II complexes displayed in the pancreatic islets

  2021cites this paper
• Invariant natural killer T cells balance B cell immunity

  2021cites this paper
• 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes

  2021cites this paper
• Effects of anti-CD20 monoclonal antibody and IL-10 on pancreatic β cell regeneration in nonobese diabetic mice

  2021cites this paper
• Modeling human T1D-associated autoimmune processes

  2021cites this paper
• Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SC) through the Galectin-9-Dependent Cell Contact Mechanism

  2021cites this paper
• Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes

  2021cites this paper
• Combined therapy of adenovirus vector mediated IGF-1 gene with anti-CD20 mAbs exerts potential beneficial role on type 1 diabetes in nonobese diabetic mice.

  2021cites this paper
• Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.

  2021cites this paper
• B Cells and Microbiota in Autoimmunity

  2021cites this paper
• HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome.

  2021cites this paper
• The Role of Regulatory B cells in Kidney Diseases

  2021cites this paper
• The Multiple Roles of B Lymphocytes in the Onset and Treatment of Type 1 Diabetes: Interactions between B Lymphocytes and T Cells

  2021cites this paper
• Microbiome and Cellular Players in Type 1 Diabetes: From Pathogenesis to Protection

  2020cites this paper
• Identifying the ‘Achilles heel’ of type 1 diabetes

  2020cites this paper
• Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?

  2020cites this paper
• Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus

  2020cites this paper
• Trauma induces expansion and activation of a memory‐like Treg population

  2020cites this paper
• Combination therapy with anti-CD20 mAb and IL-10 gene to reverse type 1 diabetes by attenuating pancreatitis and inhibiting apoptosis in NOD mice.

  2020cites this paper
• Partial remission in Brazilian children and adolescents with type 1 diabetes. Association with a haplotype of class II human leukocyte antigen and synthesis of autoantibodies

  2020cites this paper
• CTRP1 Attenuates UUO-induced Renal Fibrosis via AMPK/NOX4 Pathway in Mice

  2020cites this paper
• Prediabetes Induced by a Single Autoimmune B Cell Clone

  2020cites this paper
• Endotypes in T1D: B lymphocytes and early onset.

  2020cites this paper
• B cell helper T cells and type 1 diabetes

  2020cites this paper
• Recurrence of type 1 diabetes after beta-cell replacement

  2020cites this paper
• Follicular helper T cells in type 1 diabetes

  2020cites this paper
• Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells

  2019cites this paper
• Impaired B‐cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies

  2019cites this paper
• Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura

  2019cites this paper
• tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis

  2019cites this paper
• B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes

  2019cites this paper
• Protective role of B cells in sterile particulate-induced lung injury.

  2019cites this paper
• Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation.

  2019cites this paper
• Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?

  2019cites this paper
• Targeting antigen presentation in autoimmunity.

  2019cites this paper
• Follicular regulatory T cells are associated with β-cell autoimmunity and the development of type 1 diabetes.

  2019cites this paper
• B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.

  2019cites this paper
• Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

  2019cites this paper
• B Cell Biology and Related Therapies in SLE

  2019cites this paper
• AIRE expression controls the peripheral selection of autoreactive B cells

  2019cites this paper
• Decrease in the proportion of CD24hiCD38hi B cells and impairment of their regulatory capacity in type 1 diabetes patients

  2019cites this paper
• Physiopathologie des états diabétiques

  2019cites this paper
• Immunological aspects of allogeneic pancreatic islet transplantation: a comparison between mouse and human

  2019cites this paper
• Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice

  2019cites this paper
• B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model

  2018influential citation
• Lymphocyte dynamics during acute exercise in type one diabetes

  2018cites this paper